Advances in Stem Cell Therapy for Diabetic Foot Ulcers

Area of Science:

• Regenerative Medicine
• Biotechnology
• Wound Healing Research

Background:

• Diabetic foot ulcers (DFU) are a severe diabetes complication with high risks of infection, amputation, and mortality.
• Conventional treatments often fail due to the complex DFU microenvironment (ischemia, inflammation, neuropathy, oxidative stress).

Purpose of the Study:

• To review stem cell-based interventions for DFU treatment.
• To compare different stem cell sources and explore cell-free therapeutic approaches.
• To discuss challenges and future directions in DFU regenerative therapy.

Main Methods:

• Comprehensive literature review of stem cell sources (BM-MSCs, ADSCs, UCB-MSCs, iPSCs) and cell-free therapies (exosomes, secretomes).
• Comparative analysis of stem cell advantages and limitations.
• Evaluation of biomaterial and nanoplatform integration.

Main Results:

• Stem cells promote angiogenesis, modulate immunity, reduce oxidative damage, and remodel extracellular matrix.
• ADSCs offer easy autologous use; BM-MSCs have extensive clinical data; UCB-MSCs have low immunogenicity; iPSCs offer customization.
• Cell-free therapies (exosomes, secretomes) mimic stem cell effects with fewer safety concerns.
• Biomaterial/nanoplatforms enhance therapeutic delivery and local retention.

Conclusions:

• Stem cell and cell-free therapies offer multifaceted strategies for DFU healing.
• Challenges include standardization, dosage optimization, safety, and cost-effectiveness.
• Future research should focus on harmonizing protocols, advancing exosome therapies, and conducting large trials.